// App-Quantinova.ai

BSH2020‐PO‐017 : Whose choice is it anyway? A multi‐national and multi‐stakeholder perspective on shared treatment decision making in older adults with acute myeloid leukaemia

Researchers

Presenter

  • N. Russell

Principal Investigators

  • T. LeBlanc

  • L. Hernandez-Aldama

  • C. Panter

  • T. Bell

  • L. Morgan

  • F. Pelequin

  • A. Gater

  • V. Welch

  • L. O'Hara

  • R. Hohman

  • D. Merino

  • R. Walter

  • N. Horikoshi

  • D. Maze

Medical Centers

  • Oncology, Nottingham University Hospital, Nottingham, UK

  • Division of Hematological Malignancies and Cellular Therapy, Duke University School of Medicine, Durham

  • ArmorUp for LIFE, Philadlephia, USA

  • Patient Centred Outcomes, Adelphi Values Ltd., Bollington, UK

  • Pfizer Inc, New York, NY

  • Pfizer Canada, Montreal, QC, Canada

  • Friends of Cancer Research, Washington, DC

  • Department of Medicine/Division of Hematology, Fred Hutchinson Cancer Research Center, Seattle

  • Aplastic Anemia and MDS International Foundation, Rockville, MD

  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada

Locations

  • United Kingdom

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

  • Solid malignancies

  • Trauma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A